<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00718653</url>
  </required_header>
  <id_info>
    <org_study_id>R03EY015674</org_study_id>
    <secondary_id>R03EY015674</secondary_id>
    <nct_id>NCT00718653</nct_id>
  </id_info>
  <brief_title>Effects of Antioxidants on Human Macular Pigments</brief_title>
  <official_title>Effects of Antioxidants on Human Macular Pigments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Eye Institute (NEI)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Age-related macular degeneration (AMD) is the leading cause of blindness in the United
      States. Low dietary intake or low blood levels of lutein and zeaxanthin, which are the only
      pigments found in the macular region of the human retina, has been associated with an
      increased risk for AMD. We have reported that the dietary supplementation of lutein and
      zeaxanthin can increase the macular pigments (MP) of the eye. MP effectively absorbs blue
      light as well as quenches reactive oxygen species (ROS). Green tea polyphenols are also
      effective scavenger of ROS in vitro.

      Our goal is to elucidate how to effectively increase MP by physiologic levels of antioxidant
      supplementation. We hypothesize that lutein and tea polyphenols protect the macula of the eye
      by increasing MP carotenoids effectively through an antioxidant mechanism.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>macular pigments, Plasma lutein concentrations</measure>
    <time_frame>Every month - baseline, 1, 2, 3, &amp; 4 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Eye Health</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lutein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lutein plus green tea extract</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lutein</intervention_name>
    <description>Lutein (12 mg/d)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lutein plus green tea extract</intervention_name>
    <description>lutein (12 mg/d) plus green tea extract (200 mg/d)</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal hematologic parameters, normal serum albumin, normal liver function, normal
             kidney function, absence of fat malabsorption and no drug intake which would interfere
             with fat absorption, metabolism or blood clotting

          -  non-smokers

        Exclusion Criteria:

          -  A history of kidney stones, active small bowel disease or resection, atrophic
             gastritis, hyperlipidemia, insulin-requiring diabetes, alcoholism, pancreatic disease,
             or bleeding disorders

          -  Exogenous hormone users

          -  weighing greater than 20% above or below the NHANES median standard

          -  subjects with serum lutein/zeaxanthin concentrations that are more than 150 % of
             median of normal population (as previously reported in NHANES III at same age group)

          -  early age related macular degeneration, cataract, or glaucoma except for those with
             age appropriate progression of the eye status.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyung-Jin Yeum, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jean Mayer USDA-Human Nutrition Research Center on Aging at Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18806766</url>
  </link>
  <results_reference>
    <citation>Li L, Duker JS, Yoshida Y, Niki E, Rasmussen H, Russell RM, Yeum KJ. Oxidative stress and antioxidant status in older adults with early cataract. Eye (Lond). 2009 Jun;23(6):1464-8. doi: 10.1038/eye.2008.281. Epub 2008 Sep 19.</citation>
    <PMID>18806766</PMID>
  </results_reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2008</study_first_submitted>
  <study_first_submitted_qc>July 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2008</study_first_posted>
  <last_update_submitted>February 27, 2009</last_update_submitted>
  <last_update_submitted_qc>February 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kyung-Jin Yeum</name_title>
    <organization>Tufts Univeristy</organization>
  </responsible_party>
  <keyword>Macular pigment, lutein, green tea extract, antioxidant</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

